Q1 DELÅRSRAPPORT Januari-Mars 2025
Läs mer
Mentice Q1 2025 delårsrapport webcast
Anmäl dig nu

Magnus Nilsson

Chairman of the Board
Chairman of the Remuneration Committee

Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Doctor of Medical Science from Uppsala University. Active as management consultant (non-listed companies). Other directorships in listed companies: board member of Cantargia AB and Corline AB. Former CEO of Xvivo Perfursion AB, CEO of Vitrolife AB and board member of the listed companies Immunicum AB and Dignitana AB.

Holdings

Aktier och optioner

Shareholding in Mentice: 10,000 shares

Independent

Oberoende

Independent in relation to the company, its management, and major shareholders.

Q1 INTERIM REPORT January-March 2025
Read more
Mentice Q1 2025 Interim Report earnings call
Register now

Magnus Nilsson

Chairman of the Board
Chairman of the Remuneration Committee

Born 1956. Doctor of Medical Science (Med Dr Sc) from Uppsala University. Doctor of Medical Science from Uppsala University. Active as management consultant (non-listed companies). Other directorships in listed companies: board member of Cantargia AB and Corline AB. Former CEO of Xvivo Perfursion AB, CEO of Vitrolife AB and board member of the listed companies Immunicum AB and Dignitana AB.

Holdings

Aktier och optioner

Shareholding in Mentice: 10,000 shares

Independent

Oberoende

Independent in relation to the company, its management, and major shareholders.